- Home
- VCEL vs EVGOW Comparison
VCEL vs EVGOW Comparison
Compare VCEL & EVGOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- EVGOW
- Stock Information
- Founded
- VCEL 1989
- EVGOW 2010
- Country
- VCEL United States
- EVGOW United States
- Employees
- VCEL N/A
- EVGOW 331
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- EVGOW Other Specialty Stores
- Sector
- VCEL Health Care
- EVGOW Consumer Discretionary
- Exchange
- VCEL Nasdaq
- EVGOW Nasdaq
- Market Cap
- VCEL 2.1B
- EVGOW N/A
- IPO Year
- VCEL 1997
- EVGOW N/A
- Fundamental
- Price
- VCEL $40.15
- EVGOW N/A
- Analyst Decision
- VCEL Strong Buy
- EVGOW
- Analyst Count
- VCEL 8
- EVGOW 0
- Target Price
- VCEL $62.00
- EVGOW N/A
- AVG Volume (30 Days)
- VCEL 430.8K
- EVGOW 74.7K
- Earning Date
- VCEL 07-31-2025
- EVGOW 03-07-2025
- Dividend Yield
- VCEL N/A
- EVGOW N/A
- EPS Growth
- VCEL 521.85
- EVGOW N/A
- EPS
- VCEL 0.05
- EVGOW N/A
- Revenue
- VCEL $238,541,000.00
- EVGOW $239,306,000.00
- Revenue This Year
- VCEL $23.03
- EVGOW N/A
- Revenue Next Year
- VCEL $24.52
- EVGOW N/A
- P/E Ratio
- VCEL $705.61
- EVGOW N/A
- Revenue Growth
- VCEL 14.80
- EVGOW 73.08
- 52 Week Low
- VCEL $37.39
- EVGOW $0.12
- 52 Week High
- VCEL $63.00
- EVGOW $1.99
- Technical
- Relative Strength Index (RSI)
- VCEL 44.33
- EVGOW 37.30
- Support Level
- VCEL $40.53
- EVGOW $0.19
- Resistance Level
- VCEL $43.57
- EVGOW $0.22
- Average True Range (ATR)
- VCEL 1.62
- EVGOW 0.03
- MACD
- VCEL -0.16
- EVGOW -0.00
- Stochastic Oscillator
- VCEL 28.65
- EVGOW 24.00
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About EVGOW EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.